Warning letter
Coral Blood Services: warning letter of Aug 2, 2001
FDA warning letter UCM178304 · Chicago District Office
Key facts
| Reference number | UCM178304 |
|---|---|
| Company | Coral Blood Services |
| Subject | Standard for Human Blood & Blood Products/Adulterated |
| Issue date | Aug 2, 2001 |
| Posted date | Aug 2, 2001 |
| Issuing office | Chicago District Office |
| Product type | Biologics |
| CFR sections cited | 606.100, 640.4(h), 640.16(a) |
| Country | 3 |
| Inspection city | Chicago |
| Inspection ZIP | 60614-3363 |
| Inspection start date | Jul 11, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: